Lawrence B. Marks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lawrence B. Marks has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Donna Hollis
4 shared publicationsSu-Min Zhou
4 shared publicationsKeith L. Miller
Department of Cancer Center Biostatistics, Duke University Medical Center, Durham, NC 27710, USA
3 shared publicationsLeonard R. Prosnitz
3 shared publicationsR.Edward Coleman
Shanghai Cancer Hospital Shanghai China
3 shared publicationsRobert Clough
3 shared publications
Latest Publications
- Open Access
- 4 July 2012
- Published by Wiley in Thoracic Cancer
- Vol. 4 (2) , 123-130
Diabetes mellitus: A significant co‐morbidity in the setting of lung cancer?
Background: To evaluate the effect of diabetes mellitus (DM) on clinical outcomes in patients managed surgically for non-small cell lung cancer (NSCLC). Methods: Patients who underwent surgery for pathological I-IIIA NSCLC at Duke University from 1995–2005 were analyzed. Postoperative mortality was defined as any death occurring within 30 days of resection or during the initial hospitalization after surgery. Disease recurrence at the surgical margin, ipsilateral hilum, and/or mediastinum was considered a local/regional recurrence (LRR). Survival and LRR rates were estimated using the Kaplan-Meier method and compared using a log rank test. A multivariate regression analysis assessed the association between candidate factors, including DM, and disease recurrence and survival. Results: Of 957 patients, DM was present in 122 (13%). DM was associated with an increased risk of postoperative mortality (7.4% vs. 3.2%, P= 0.04). However, the proportion of patients undergoing sublobar resections, mediastinal lymph node dissection, and receiving adjuvant chemotherapy, was no different among patients with or without DM. Five-year LRR rates were 27% in patients with DM, versus 21% in patients without DM (P= 0.23). Survival at five years was 43% for patients with DM, and 47% for patients without DM (P= 0.10). On multivariate analysis, DM was not independently associated with a higher risk of LRR (hazard ratio [HR] 1.33, P= 0.34), distant recurrence (HR 0.86, P= 0.58), or overall survival (HR 1.08, P= 0.63). Conclusions: Although a higher risk of postoperative mortality was noted in patients with DM, a detriment in local or distant disease control or overall survival was not observed.
- 4 July 2012
- Published by Wiley in Thoracic Cancer
- Vol. 4 (2) , 123-130
Open AccessDiabetes mellitus: A significant co‐morbidity in the setting of lung cancer?
Background: To evaluate the effect of diabetes mellitus (DM) on clinical outcomes in patients managed surgically for non-small cell lung cancer (NSCLC). Methods: Patients who underwent surgery for pathological I-IIIA NSCLC at Duke University from 1995–2005 were analyzed. Postoperative mortality was defined as any death occurring within 30 days of resection or during the initial hospitalization after surgery. Disease recurrence at the surgical margin, ipsilateral hilum, and/or mediastinum was considered a local/regional recurrence (LRR). Survival and LRR rates were estimated using the Kaplan-Meier method and compared using a log rank test. A multivariate regression analysis assessed the association between candidate factors, including DM, and disease recurrence and survival. Results: Of 957 patients, DM was present in 122 (13%). DM was associated with an increased risk of postoperative mortality (7.4% vs. 3.2%, P= 0.04). However, the proportion of patients undergoing sublobar resections, mediastinal lymph node dissection, and receiving adjuvant chemotherapy, was no different among patients with or without DM. Five-year LRR rates were 27% in patients with DM, versus 21% in patients without DM (P= 0.23). Survival at five years was 43% for patients with DM, and 47% for patients without DM (P= 0.10). On multivariate analysis, DM was not independently associated with a higher risk of LRR (hazard ratio [HR] 1.33, P= 0.34), distant recurrence (HR 0.86, P= 0.58), or overall survival (HR 1.08, P= 0.63). Conclusions: Although a higher risk of postoperative mortality was noted in patients with DM, a detriment in local or distant disease control or overall survival was not observed.
- 1 July 2012
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 83 (3) , 814-820
Breast Conservation Therapy: The Influence of Molecular Subtype and Margins
- 1 July 2012
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 83 (3) , 814-820
Breast Conservation Therapy: The Influence of Molecular Subtype and Margins
- 1 January 2008
- Vol. 22 (1) , 37
Radiation-induced lung injury. Assessment, management, and prevention.
Radiation therapy (RT) is an important treatment modality for multiple thoracic malignancies. Incidental irradiation of the lungs, which are particularly susceptible to injury, is unavoidable and often dose-limiting. The most radiosensitive subunit of the lung is the alveolar/capillary complex, and RT-induced lung injury is often described as diffuse alveolar damage. Reactive oxygen species generated by RT are directly toxic to parenchymal cells and initiate a cascade of molecular events that alter the cytokine milieu of the microenvironment, creating a self-sustaining cycle of inflammation and chronic oxidative stress. Replacement of normal lung parenchyma by fibrosis is the culminating event. Depending on the dose and volume of lung irradiated, acute radiation pneumonitis may develop, characterized by dry cough and dyspnea. Fibrosis of the lung, which can also cause dyspnea, is the late complication. Imaging studies and pulmonary function tests can be used to quantify the extent of lung injury. While strict dose-volume constraints to minimize the risk of injury are difficult to impose, substantial data support some general guidelines. New modalities such as intensity-modulated radiation therapy and stereotactic body radiation therapy provide new treatment options but also pose new challenges in safely delivering thoracic RT.
- 1 January 2008
- Vol. 22 (1) , 37
Radiation-induced lung injury. Assessment, management, and prevention.
Radiation therapy (RT) is an important treatment modality for multiple thoracic malignancies. Incidental irradiation of the lungs, which are particularly susceptible to injury, is unavoidable and often dose-limiting. The most radiosensitive subunit of the lung is the alveolar/capillary complex, and RT-induced lung injury is often described as diffuse alveolar damage. Reactive oxygen species generated by RT are directly toxic to parenchymal cells and initiate a cascade of molecular events that alter the cytokine milieu of the microenvironment, creating a self-sustaining cycle of inflammation and chronic oxidative stress. Replacement of normal lung parenchyma by fibrosis is the culminating event. Depending on the dose and volume of lung irradiated, acute radiation pneumonitis may develop, characterized by dry cough and dyspnea. Fibrosis of the lung, which can also cause dyspnea, is the late complication. Imaging studies and pulmonary function tests can be used to quantify the extent of lung injury. While strict dose-volume constraints to minimize the risk of injury are difficult to impose, substantial data support some general guidelines. New modalities such as intensity-modulated radiation therapy and stereotactic body radiation therapy provide new treatment options but also pose new challenges in safely delivering thoracic RT.
- 31 December 2006
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 67 (1) , 178-186
Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis
- 31 December 2006
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 67 (1) , 178-186
Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis
- 1 September 2005
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 63 (1) , 214-223
The incidence and functional consequences of RT-associated cardiac perfusion defects
- 1 September 2005
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 63 (1) , 214-223
The incidence and functional consequences of RT-associated cardiac perfusion defects
- 14 March 2005
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 62 (4) , 1009-1013
Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity
- 14 March 2005
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 62 (4) , 1009-1013
Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity
- 31 October 2004
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 14 (4) , 298-307
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
- 31 October 2004
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 14 (4) , 298-307
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
- Open Access
- 1 September 2004
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 5 (4) , 1-14
A dose‐volume‐based tool for evaluating and ranking IMRT treatment plans
A dose-volume based tool for evaluating and ranking IMRT treatment plans
- 1 September 2004
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 5 (4) , 1-14
Open AccessA dose‐volume‐based tool for evaluating and ranking IMRT treatment plans
A dose-volume based tool for evaluating and ranking IMRT treatment plans
- 26 July 2004
- Published by Wiley in Medical Physics
- Vol. 31 (8) , 2335-2343
Penalized likelihood fluence optimization with evolutionary components for intensity modulated radiation therapy treatment planning
A novel iterative penalized likelihood algorithm with evolutionary components for the optimization of beamlet fluences for intensity modulated radiation therapy (IMRT) is presented. This algorithm is designed to be flexible in terms of the objective function and automatically escalates dose, as long as the objective function increases and all constraints are met. For this study, the objective function employed was the product of target equivalent uniform dose (EUD) and fraction of target tissue within set homogeneity constraints. The likelihood component of the algorithm iteratively attempts to minimize the mean squared error between a homogeneous dose prescription and the actual target dose distribution. The updated beamlet fluences are then adjusted via a quadratic penalty function that is based on the dose-volume histogram (DVH) constraints of the organs at risk. The evolutionary components were included to prevent the algorithm from converging to a local maximum. The algorithm was applied to a prostate cancer dataset, with especially difficult DVH constraints on bladder, rectum, and femoral heads. Dose distributions were generated for manually selected sets of three-, four-, five-, and seven-field treatment plans. Additionally, a global search was performed to find the optimal orientations for an axial three-beam plan. The results from this optimal orientation set were compared to results for manually selected orientation (gantry angle) sets of 3- (0 degrees, 90 degrees, 270 degrees), 4- (0 degrees, 90 degrees, 180 degrees, 270 degrees), 5- (0 degrees, 50 degrees, 130 degrees, 230 degrees, 310 degrees), and 7- (0 degrees, 40 degrees, 90 degrees, 140 degrees, 230 degrees, 270 degrees, 320 degrees) field axial treatment plans. For all the plans generated, all DVH constraints were met and average optimization computation time was approximately 30 seconds. For the manually selected orientations, the algorithm was successful in providing a relatively homogeneous target dose distribution, while simultaneously satisfying dose-volume limits by diverting dose away from proximal critical structures. The global search for an optimal three-beam orientation set yielded gantry angles of 70 degrees, 170 degrees, and 320 degrees. The EUD for this orientation set was 58 Gy, with 96% of the target within the set upper and lower limits. In comparison, optimized EUDs for the manually selected orientation sets of three, four, five and seven beams were 52.3, 52.6, 56.9, and 61.3 Gy, respectively. The orientation optimized three-beam plan yielded higher EUDs than the manually selected three-, four-, and five-beam plans, but lower EUDs than the seven-beam plan. In conclusion, a novel penalized likelihood algorithm with evolutionary components has successfully been implemented to optimize beamlet fluences for IMRT. Initial results are promising for dose conformity and uniformity of dose to target. When combined with optimal beam orientation selection for prostate cancer treatment planning, the results indicate that plans with a small number of optimized beam orientations achieve results comparable to those with a larger number of conventionally oriented beams.
- 26 July 2004
- Published by Wiley in Medical Physics
- Vol. 31 (8) , 2335-2343
Penalized likelihood fluence optimization with evolutionary components for intensity modulated radiation therapy treatment planning
A novel iterative penalized likelihood algorithm with evolutionary components for the optimization of beamlet fluences for intensity modulated radiation therapy (IMRT) is presented. This algorithm is designed to be flexible in terms of the objective function and automatically escalates dose, as long as the objective function increases and all constraints are met. For this study, the objective function employed was the product of target equivalent uniform dose (EUD) and fraction of target tissue within set homogeneity constraints. The likelihood component of the algorithm iteratively attempts to minimize the mean squared error between a homogeneous dose prescription and the actual target dose distribution. The updated beamlet fluences are then adjusted via a quadratic penalty function that is based on the dose-volume histogram (DVH) constraints of the organs at risk. The evolutionary components were included to prevent the algorithm from converging to a local maximum. The algorithm was applied to a prostate cancer dataset, with especially difficult DVH constraints on bladder, rectum, and femoral heads. Dose distributions were generated for manually selected sets of three-, four-, five-, and seven-field treatment plans. Additionally, a global search was performed to find the optimal orientations for an axial three-beam plan. The results from this optimal orientation set were compared to results for manually selected orientation (gantry angle) sets of 3- (0 degrees, 90 degrees, 270 degrees), 4- (0 degrees, 90 degrees, 180 degrees, 270 degrees), 5- (0 degrees, 50 degrees, 130 degrees, 230 degrees, 310 degrees), and 7- (0 degrees, 40 degrees, 90 degrees, 140 degrees, 230 degrees, 270 degrees, 320 degrees) field axial treatment plans. For all the plans generated, all DVH constraints were met and average optimization computation time was approximately 30 seconds. For the manually selected orientations, the algorithm was successful in providing a relatively homogeneous target dose distribution, while simultaneously satisfying dose-volume limits by diverting dose away from proximal critical structures. The global search for an optimal three-beam orientation set yielded gantry angles of 70 degrees, 170 degrees, and 320 degrees. The EUD for this orientation set was 58 Gy, with 96% of the target within the set upper and lower limits. In comparison, optimized EUDs for the manually selected orientation sets of three, four, five and seven beams were 52.3, 52.6, 56.9, and 61.3 Gy, respectively. The orientation optimized three-beam plan yielded higher EUDs than the manually selected three-, four-, and five-beam plans, but lower EUDs than the seven-beam plan. In conclusion, a novel penalized likelihood algorithm with evolutionary components has successfully been implemented to optimize beamlet fluences for IMRT. Initial results are promising for dose conformity and uniformity of dose to target. When combined with optimal beam orientation selection for prostate cancer treatment planning, the results indicate that plans with a small number of optimized beam orientations achieve results comparable to those with a larger number of conventionally oriented beams.
- 1 August 2003
- Published by Elsevier in Clinical Breast Cancer
- Vol. 4 (3) , 198-202
Increased Sectioning of Pathologic Specimens with Ductal Carcinoma In Situ of the Breast: Are There Clinical Consequences?
- 1 August 2003
- Published by Elsevier in Clinical Breast Cancer
- Vol. 4 (3) , 198-202
Increased Sectioning of Pathologic Specimens with Ductal Carcinoma In Situ of the Breast: Are There Clinical Consequences?